| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.069 | 0.2 |